Parse Biosciences Closes $42.5M Series B Round
The Seattle-based company is planning to scale up the commercialization of its single-cell, whole-transcriptome assays and expand its product portfolio.
Source: genomeweb.com
Page 3 - Evercode Whole Transcriptome News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evercode Whole Transcriptome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evercode Whole Transcriptome Today - Breaking & Trending Today
Parse Biosciences Closes $41.5M Series B Round
The Seattle-based company is planning to scale up the commercialization of its single-cell, whole-transcriptome assays and expand its product portfolio.
Source: genomeweb.com
Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution
The partnership brings Parse’s single-cell sequencing kits, previously available in North America, Europe, Australia, and New Zealand, to the APAC region.
Source: genomeweb.com